We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: NKTR Drug delivery Company

08 Nov 2017 11:57 PM <--
08 Mar 2010 10:14 AM
12 Apr 2007 11:55 AM
21 Mar 2006 01:40 PM
06 Oct 2005 08:51 AM

Return to NKTR Drug delivery Company
Subject 11419

Nektar Therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform.

Cancer and Pain Products